Cargando…
Changing Incidence of Invasive Pneumococcal Disease in Infants Less Than 90 Days of Age Before and After Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Blantyre, Malawi: A 14-Year Hospital Based Surveillance Study
BACKGROUND: Invasive pneumococcal disease (IPD) in young infants is uncommon but associated with high morbidity and mortality. Accurate data on the burden of IPD in young infants in low-income countries are lacking. We examined the burden of IPD in infants <90 days old in Blantyre, Malawi over a...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359774/ https://www.ncbi.nlm.nih.gov/pubmed/35703302 http://dx.doi.org/10.1097/INF.0000000000003606 |
_version_ | 1784764205884243968 |
---|---|
author | Koenraads, Marianne Swarthout, Todd D. Bar-Zeev, Naor Brown, Comfort Msefula, Jacquline Denis, Brigitte Dube, Queen Gordon, Stephen B. Heyderman, Robert S. Gladstone, Melissa J. French, Neil |
author_facet | Koenraads, Marianne Swarthout, Todd D. Bar-Zeev, Naor Brown, Comfort Msefula, Jacquline Denis, Brigitte Dube, Queen Gordon, Stephen B. Heyderman, Robert S. Gladstone, Melissa J. French, Neil |
author_sort | Koenraads, Marianne |
collection | PubMed |
description | BACKGROUND: Invasive pneumococcal disease (IPD) in young infants is uncommon but associated with high morbidity and mortality. Accurate data on the burden of IPD in young infants in low-income countries are lacking. We examined the burden of IPD in infants <90 days old in Blantyre, Malawi over a 14-year period and evaluated the indirect impact of the 13-valent pneumococcal conjugate vaccine (PCV13) on vaccine-serotype IPD (VT-IPD) in this population. METHODS: We conducted laboratory-based prospective IPD surveillance in infants <90 days of age admitted to Queen Elizabeth Central Hospital in Blantyre between 2005 and 2018, including 7 years pre-PCV13 and 7 years post-PCV13 introduction. IPD was defined as Streptococcus pneumoniae identified by culture from blood or cerebrospinal fluid. Serotypes were determined by multiplex polymerase chain reaction and latex agglutination testing. RESULTS: We identified 130 cases of culture-confirmed IPD in infants <90 days old between 2005 and 2018. Total IPD incidence was declining before PCV13 introduction. The mean incidence of IPD was significantly lower in the post-PCV13 era. Serotypes 5 (27.8%) and 1 (15.6%) were most prevalent. Even after PCV13 introduction, VTs remained the primary cause of IPD, with serotype 5 accounting for 17.4% and serotype 1 for 13.0% of cases in young infants. CONCLUSION: Vaccine serotypes 1 and 5 were the main cause of IPD in neonates and young infants, both before and after PCV13 introduction. This suggests incomplete indirect protection with persisting VT carriage across the population despite vaccination in this setting. Alternative vaccine schedules and other vaccine introduction approaches need to be considered to protect this vulnerable population. |
format | Online Article Text |
id | pubmed-9359774 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-93597742022-08-11 Changing Incidence of Invasive Pneumococcal Disease in Infants Less Than 90 Days of Age Before and After Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Blantyre, Malawi: A 14-Year Hospital Based Surveillance Study Koenraads, Marianne Swarthout, Todd D. Bar-Zeev, Naor Brown, Comfort Msefula, Jacquline Denis, Brigitte Dube, Queen Gordon, Stephen B. Heyderman, Robert S. Gladstone, Melissa J. French, Neil Pediatr Infect Dis J Vaccine Reports BACKGROUND: Invasive pneumococcal disease (IPD) in young infants is uncommon but associated with high morbidity and mortality. Accurate data on the burden of IPD in young infants in low-income countries are lacking. We examined the burden of IPD in infants <90 days old in Blantyre, Malawi over a 14-year period and evaluated the indirect impact of the 13-valent pneumococcal conjugate vaccine (PCV13) on vaccine-serotype IPD (VT-IPD) in this population. METHODS: We conducted laboratory-based prospective IPD surveillance in infants <90 days of age admitted to Queen Elizabeth Central Hospital in Blantyre between 2005 and 2018, including 7 years pre-PCV13 and 7 years post-PCV13 introduction. IPD was defined as Streptococcus pneumoniae identified by culture from blood or cerebrospinal fluid. Serotypes were determined by multiplex polymerase chain reaction and latex agglutination testing. RESULTS: We identified 130 cases of culture-confirmed IPD in infants <90 days old between 2005 and 2018. Total IPD incidence was declining before PCV13 introduction. The mean incidence of IPD was significantly lower in the post-PCV13 era. Serotypes 5 (27.8%) and 1 (15.6%) were most prevalent. Even after PCV13 introduction, VTs remained the primary cause of IPD, with serotype 5 accounting for 17.4% and serotype 1 for 13.0% of cases in young infants. CONCLUSION: Vaccine serotypes 1 and 5 were the main cause of IPD in neonates and young infants, both before and after PCV13 introduction. This suggests incomplete indirect protection with persisting VT carriage across the population despite vaccination in this setting. Alternative vaccine schedules and other vaccine introduction approaches need to be considered to protect this vulnerable population. Lippincott Williams & Wilkins 2022-06-13 2022-09 /pmc/articles/PMC9359774/ /pubmed/35703302 http://dx.doi.org/10.1097/INF.0000000000003606 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Vaccine Reports Koenraads, Marianne Swarthout, Todd D. Bar-Zeev, Naor Brown, Comfort Msefula, Jacquline Denis, Brigitte Dube, Queen Gordon, Stephen B. Heyderman, Robert S. Gladstone, Melissa J. French, Neil Changing Incidence of Invasive Pneumococcal Disease in Infants Less Than 90 Days of Age Before and After Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Blantyre, Malawi: A 14-Year Hospital Based Surveillance Study |
title | Changing Incidence of Invasive Pneumococcal Disease in Infants Less Than 90 Days of Age Before and After Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Blantyre, Malawi: A 14-Year Hospital Based Surveillance Study |
title_full | Changing Incidence of Invasive Pneumococcal Disease in Infants Less Than 90 Days of Age Before and After Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Blantyre, Malawi: A 14-Year Hospital Based Surveillance Study |
title_fullStr | Changing Incidence of Invasive Pneumococcal Disease in Infants Less Than 90 Days of Age Before and After Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Blantyre, Malawi: A 14-Year Hospital Based Surveillance Study |
title_full_unstemmed | Changing Incidence of Invasive Pneumococcal Disease in Infants Less Than 90 Days of Age Before and After Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Blantyre, Malawi: A 14-Year Hospital Based Surveillance Study |
title_short | Changing Incidence of Invasive Pneumococcal Disease in Infants Less Than 90 Days of Age Before and After Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Blantyre, Malawi: A 14-Year Hospital Based Surveillance Study |
title_sort | changing incidence of invasive pneumococcal disease in infants less than 90 days of age before and after introduction of the 13-valent pneumococcal conjugate vaccine in blantyre, malawi: a 14-year hospital based surveillance study |
topic | Vaccine Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359774/ https://www.ncbi.nlm.nih.gov/pubmed/35703302 http://dx.doi.org/10.1097/INF.0000000000003606 |
work_keys_str_mv | AT koenraadsmarianne changingincidenceofinvasivepneumococcaldiseaseininfantslessthan90daysofagebeforeandafterintroductionofthe13valentpneumococcalconjugatevaccineinblantyremalawia14yearhospitalbasedsurveillancestudy AT swarthouttoddd changingincidenceofinvasivepneumococcaldiseaseininfantslessthan90daysofagebeforeandafterintroductionofthe13valentpneumococcalconjugatevaccineinblantyremalawia14yearhospitalbasedsurveillancestudy AT barzeevnaor changingincidenceofinvasivepneumococcaldiseaseininfantslessthan90daysofagebeforeandafterintroductionofthe13valentpneumococcalconjugatevaccineinblantyremalawia14yearhospitalbasedsurveillancestudy AT browncomfort changingincidenceofinvasivepneumococcaldiseaseininfantslessthan90daysofagebeforeandafterintroductionofthe13valentpneumococcalconjugatevaccineinblantyremalawia14yearhospitalbasedsurveillancestudy AT msefulajacquline changingincidenceofinvasivepneumococcaldiseaseininfantslessthan90daysofagebeforeandafterintroductionofthe13valentpneumococcalconjugatevaccineinblantyremalawia14yearhospitalbasedsurveillancestudy AT denisbrigitte changingincidenceofinvasivepneumococcaldiseaseininfantslessthan90daysofagebeforeandafterintroductionofthe13valentpneumococcalconjugatevaccineinblantyremalawia14yearhospitalbasedsurveillancestudy AT dubequeen changingincidenceofinvasivepneumococcaldiseaseininfantslessthan90daysofagebeforeandafterintroductionofthe13valentpneumococcalconjugatevaccineinblantyremalawia14yearhospitalbasedsurveillancestudy AT gordonstephenb changingincidenceofinvasivepneumococcaldiseaseininfantslessthan90daysofagebeforeandafterintroductionofthe13valentpneumococcalconjugatevaccineinblantyremalawia14yearhospitalbasedsurveillancestudy AT heydermanroberts changingincidenceofinvasivepneumococcaldiseaseininfantslessthan90daysofagebeforeandafterintroductionofthe13valentpneumococcalconjugatevaccineinblantyremalawia14yearhospitalbasedsurveillancestudy AT gladstonemelissaj changingincidenceofinvasivepneumococcaldiseaseininfantslessthan90daysofagebeforeandafterintroductionofthe13valentpneumococcalconjugatevaccineinblantyremalawia14yearhospitalbasedsurveillancestudy AT frenchneil changingincidenceofinvasivepneumococcaldiseaseininfantslessthan90daysofagebeforeandafterintroductionofthe13valentpneumococcalconjugatevaccineinblantyremalawia14yearhospitalbasedsurveillancestudy |